Comparison

Molecules

1437732 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Ozanimod hydrochloride Chemicals Other respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding DCC-DC59005-100mg

DCChemicals
100 mg Login
Compare
Ozanimod hydrochloride Chemicals Other respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding DCC-DC59005-250mg

DCChemicals
250 mg Login
Compare
Ozanimod hydrochloride Chemicals Other respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding DCC-DC59005-1g

DCChemicals
1 g Login
Compare
EHP-­101 (VCE-­ 004.8) Chemicals Other EHP-101 (VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. EHP-101 inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. EHP-101 attenuates adipogenesis and prevents diet-induced obesity. EHP-101 (20 mg/kg/day; i.p.; for 3 weeks) induces a significant red, total fat mass, adipocyte volume and plasma triglycerides levels in HFD mice. DCC-DC57061-100mg

DCChemicals
100 mg Login
Compare
EHP-­101 (VCE-­ 004.8) Chemicals Other EHP-101 (VCE-004.8) is an orally active, total fat mass, adipocyte volume and plasma triglycerides levels in HFD mice., specific PPARγ and CB2 receptor dual agonist. EHP-101 inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. EHP-101 attenuates adipogenesis and prevents diet-induced obesity. EHP-101 (20 mg/kg/day; i.p.; for 3 weeks) induces a significant red DCC-DC57061-250mg

DCChemicals
250 mg Login
Compare
EHP-­101 (VCE-­ 004.8) Chemicals Other EHP-101 (VCE-004.8) is an orally active, total fat mass, adipocyte volume and plasma triglycerides levels in HFD mice., specific PPARγ and CB2 receptor dual agonist. EHP-101 inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. EHP-101 attenuates adipogenesis and prevents diet-induced obesity. EHP-101 (20 mg/kg/day; i.p.; for 3 weeks) induces a significant red DCC-DC57061-1g

DCChemicals
1 g Login
Compare
VX-­150 Chemicals Other VX-150 (EOS-62073), a NaV1.8 blocker, is currently in a phase II clinical trial for the treatment of patients with acute pain. VX-150 significantly alleviates postoperative pain. DCC-DC57073-100mg

DCChemicals
100 mg Login
Compare
VX-­150 Chemicals Other VX-150 (EOS-62073), a NaV1.8 blocker, is currently in a phase II clinical trial for the treatment of patients with acute pain. VX-150 significantly alleviates postoperative pain. DCC-DC57073-250mg

DCChemicals
250 mg Login
Compare
VX-­150 Chemicals Other VX-150 (EOS-62073), a NaV1.8 blocker, is currently in a phase II clinical trial for the treatment of patients with acute pain. VX-150 significantly alleviates postoperative pain. DCC-DC57073-1g

DCChemicals
1 g Login
Compare
XEN723 Chemicals Other respectively., XEN723 is a novel and potent thiazolylimidazolidinone inhibitor of Stearoyl-CoA Desaturase (SCD1) with IC50s of 45 and 524 nM in mouse and HepG2 cell DCC-DC57080-100mg

DCChemicals
100 mg Login
Compare
XEN723 Chemicals Other respectively., XEN723 is a novel and potent thiazolylimidazolidinone inhibitor of Stearoyl-CoA Desaturase (SCD1) with IC50s of 45 and 524 nM in mouse and HepG2 cell DCC-DC57080-250mg

DCChemicals
250 mg Login
Compare
XEN723 Chemicals Other respectively., XEN723 is a novel and potent thiazolylimidazolidinone inhibitor of Stearoyl-CoA Desaturase (SCD1) with IC50s of 45 and 524 nM in mouse and HepG2 cell DCC-DC57080-1g

DCChemicals
1 g Login
Compare
FIDAS-­3 Chemicals Other FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities. DCC-DC57081-100mg

DCChemicals
100 mg Login
Compare
FIDAS-­3 Chemicals Other FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities. DCC-DC57081-250mg

DCChemicals
250 mg Login
Compare
FIDAS-­3 Chemicals Other FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities. DCC-DC57081-1g

DCChemicals
1 g Login
Compare
HB007 Chemicals Other HB007 is a novel small-molecule degraders of the small ubiquitin-related modifier 1 (SUMO1). DCC-DC57071-50mg

DCChemicals
50 mg Login
Compare
HB007 Chemicals Other HB007 is a novel small-molecule degraders of the small ubiquitin-related modifier 1 (SUMO1). DCC-DC57071-100mg

DCChemicals
100 mg Login
Compare
HB007 Chemicals Other HB007 is a novel small-molecule degraders of the small ubiquitin-related modifier 1 (SUMO1). DCC-DC57071-250mg

DCChemicals
250 mg Login
Compare
MIPS-­521 Chemicals Other MIPS521 is a positive allosteric modulator of the adenosine A1 receptor. DCC-DC57090-100mg

DCChemicals
100 mg Login
Compare
Benzenepentanol Chemicals Other Oxyphyllacinol, also known as Benzenepentanol, is a natural product found in Alpinia oxyphylla (Yizhi) capsularfruits which are commonly used in traditional medicine. Oxyphyllacinol is an antioxidant. DCC-DC60026-100mg

DCChemicals
100 mg Login
Compare
MC-­MMAE Chemicals Other ELISA DCC-DC57082-100mg

DCChemicals
100 mg Login
Compare
MB-­07344 Chemicals Other MB-07344 is a TH receptor beta agonist and anticholesteremic agent; active metabolite of MB07811. DCC-DC60035-100mg

DCChemicals
100 mg Login
Compare
SU0268 Chemicals Other SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in DCC-DC57088-100mg

DCChemicals
100 mg Login
Compare
SU0268 Chemicals Other SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in DCC-DC57088-250mg

DCChemicals
250 mg Login
Compare
SU0268 Chemicals Other SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in DCC-DC57088-1g

DCChemicals
1 g Login
Compare
Name Price
Ozanimod hydrochloride Login
Type Chemicals
Clone
Specific against Other
Appl. respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding
Host
Item no.
Amount 100 mg
Available
Ozanimod hydrochloride Login
Type Chemicals
Clone
Specific against Other
Appl. respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding
Host
Item no.
Amount 250 mg
Available
Ozanimod hydrochloride Login
Type Chemicals
Clone
Specific against Other
Appl. respectively., Ozanimod is a potent and selective S1P1 and S1P5 receptor agonist with EC50s of 410±160 pM and 11±4.3 nM in [35S]-GTPγS binding
Host
Item no.
Amount 1 g
Available
EHP-­101 (VCE-­ 004.8) Login
Type Chemicals
Clone
Specific against Other
Appl. EHP-101 (VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. EHP-101 inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. EHP-101 attenuates adipogenesis and prevents diet-induced obesity. EHP-101 (20 mg/kg/day; i.p.; for 3 weeks) induces a significant red, total fat mass, adipocyte volume and plasma triglycerides levels in HFD mice.
Host
Item no.
Amount 100 mg
Available
EHP-­101 (VCE-­ 004.8) Login
Type Chemicals
Clone
Specific against Other
Appl. EHP-101 (VCE-004.8) is an orally active, total fat mass, adipocyte volume and plasma triglycerides levels in HFD mice., specific PPARγ and CB2 receptor dual agonist. EHP-101 inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. EHP-101 attenuates adipogenesis and prevents diet-induced obesity. EHP-101 (20 mg/kg/day; i.p.; for 3 weeks) induces a significant red
Host
Item no.
Amount 250 mg
Available
EHP-­101 (VCE-­ 004.8) Login
Type Chemicals
Clone
Specific against Other
Appl. EHP-101 (VCE-004.8) is an orally active, total fat mass, adipocyte volume and plasma triglycerides levels in HFD mice., specific PPARγ and CB2 receptor dual agonist. EHP-101 inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. EHP-101 attenuates adipogenesis and prevents diet-induced obesity. EHP-101 (20 mg/kg/day; i.p.; for 3 weeks) induces a significant red
Host
Item no.
Amount 1 g
Available
VX-­150 Login
Type Chemicals
Clone
Specific against Other
Appl. VX-150 (EOS-62073), a NaV1.8 blocker, is currently in a phase II clinical trial for the treatment of patients with acute pain. VX-150 significantly alleviates postoperative pain.
Host
Item no.
Amount 100 mg
Available
VX-­150 Login
Type Chemicals
Clone
Specific against Other
Appl. VX-150 (EOS-62073), a NaV1.8 blocker, is currently in a phase II clinical trial for the treatment of patients with acute pain. VX-150 significantly alleviates postoperative pain.
Host
Item no.
Amount 250 mg
Available
VX-­150 Login
Type Chemicals
Clone
Specific against Other
Appl. VX-150 (EOS-62073), a NaV1.8 blocker, is currently in a phase II clinical trial for the treatment of patients with acute pain. VX-150 significantly alleviates postoperative pain.
Host
Item no.
Amount 1 g
Available
XEN723 Login
Type Chemicals
Clone
Specific against Other
Appl. respectively., XEN723 is a novel and potent thiazolylimidazolidinone inhibitor of Stearoyl-CoA Desaturase (SCD1) with IC50s of 45 and 524 nM in mouse and HepG2 cell
Host
Item no.
Amount 100 mg
Available
XEN723 Login
Type Chemicals
Clone
Specific against Other
Appl. respectively., XEN723 is a novel and potent thiazolylimidazolidinone inhibitor of Stearoyl-CoA Desaturase (SCD1) with IC50s of 45 and 524 nM in mouse and HepG2 cell
Host
Item no.
Amount 250 mg
Available
XEN723 Login
Type Chemicals
Clone
Specific against Other
Appl. respectively., XEN723 is a novel and potent thiazolylimidazolidinone inhibitor of Stearoyl-CoA Desaturase (SCD1) with IC50s of 45 and 524 nM in mouse and HepG2 cell
Host
Item no.
Amount 1 g
Available
FIDAS-­3 Login
Type Chemicals
Clone
Specific against Other
Appl. FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities.
Host
Item no.
Amount 100 mg
Available
FIDAS-­3 Login
Type Chemicals
Clone
Specific against Other
Appl. FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities.
Host
Item no.
Amount 250 mg
Available
FIDAS-­3 Login
Type Chemicals
Clone
Specific against Other
Appl. FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities.
Host
Item no.
Amount 1 g
Available
HB007 Login
Type Chemicals
Clone
Specific against Other
Appl. HB007 is a novel small-molecule degraders of the small ubiquitin-related modifier 1 (SUMO1).
Host
Item no.
Amount 50 mg
Available
HB007 Login
Type Chemicals
Clone
Specific against Other
Appl. HB007 is a novel small-molecule degraders of the small ubiquitin-related modifier 1 (SUMO1).
Host
Item no.
Amount 100 mg
Available
HB007 Login
Type Chemicals
Clone
Specific against Other
Appl. HB007 is a novel small-molecule degraders of the small ubiquitin-related modifier 1 (SUMO1).
Host
Item no.
Amount 250 mg
Available
MIPS-­521 Login
Type Chemicals
Clone
Specific against Other
Appl. MIPS521 is a positive allosteric modulator of the adenosine A1 receptor.
Host
Item no.
Amount 100 mg
Available
Benzenepentanol Login
Type Chemicals
Clone
Specific against Other
Appl. Oxyphyllacinol, also known as Benzenepentanol, is a natural product found in Alpinia oxyphylla (Yizhi) capsularfruits which are commonly used in traditional medicine. Oxyphyllacinol is an antioxidant.
Host
Item no.
Amount 100 mg
Available
MC-­MMAE Login
Type Chemicals
Clone
Specific against Other
Appl. ELISA
Host
Item no.
Amount 100 mg
Available
MB-­07344 Login
Type Chemicals
Clone
Specific against Other
Appl. MB-07344 is a TH receptor beta agonist and anticholesteremic agent; active metabolite of MB07811.
Host
Item no.
Amount 100 mg
Available
SU0268 Login
Type Chemicals
Clone
Specific against Other
Appl. SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in
Host
Item no.
Amount 100 mg
Available
SU0268 Login
Type Chemicals
Clone
Specific against Other
Appl. SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in
Host
Item no.
Amount 250 mg
Available
SU0268 Login
Type Chemicals
Clone
Specific against Other
Appl. SU0268 is a potent and selective OGG1 inhibitor. DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in
Host
Item no.
Amount 1 g
Available

1437732 Item(s)

per page